Drug
Who makes infliximab?
2 companies list infliximab as a human prescription drug, including under the names REMICADE, Renflexis. Forms: injection, powder, lyophilized, for solution. Routes: intravenous.
Labellers from the openFDA NDC Directory. A labeller is the firm named on the label, not necessarily the site that made the product, and a listing is not an FDA approval. Data as of 24 Sept 2026. Methodology
Companies listing infliximab
| Company | Forms | Application | NDCs | Registered sites |
|---|---|---|---|---|
| Janssen Pharmaceuticals, Inc. | injection, powder, lyophilized, for solution | BLABLA103772 | 2 | 0 |
| Organon LLCNetherlands | injection, powder, lyophilized, for solution | BLABLA761054 | 1 | 4 |
Bulk ingredient listings
- Samsung Biologics Co., Ltd.United States · 2 NDC
- Boehringer Ingelheim Biopharmaceuticals China LtdGermany · 1 NDC
- Janssen Pharmaceuticals Sciences Unlimited Company · 1 NDC
Enquiry
Common questions
- Who makes infliximab?
- 2 companies list infliximab as a human prescription drug in the openFDA NDC Directory, led by Janssen Pharmaceuticals, Inc., Organon LLC. Each is the labeller, the firm named on the label; the product may be made at a site registered to another company.
- Who supplies infliximab active ingredient?
- 3 companies list infliximab as a bulk ingredient, including Samsung Biologics Co., Ltd., Boehringer Ingelheim Biopharmaceuticals China Ltd, Janssen Pharmaceuticals Sciences Unlimited Company.